Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

TPG RE Finance Trust – Q1 2026 Overview

TPG RE Finance Trust ended the first quarter of 2026 with a $4.3 billion loan investment portfolio, up to 100% performing loans and a 3.0 weighted-average risk rating. The company reported $172.8 million of liquidity and $1.5 billion of available financing capacity, while debt-to-equity stood at 3.1x.

Book value per share was $11.06 at March 31, 2026. Based on the May 29 closing share price of $8.40, the stock traded at 0.76x book value and carried an 11.4% annualized dividend yield. The dividend declared for the quarter was $0.24 per common share.

For the quarter, GAAP income per diluted share was $0.19, while distributable earnings per diluted share were $0.25. That compares with the $0.24 common dividend declared, leaving earnings slightly above the payout.

The portfolio was almost entirely floating rate at 99.6%, with a weighted-average all-in yield of 7.10% and a weighted-average credit spread of 3.17%. Weighted-average cost of funds was 1.80%, producing a spread of 5.30 percentage points between portfolio yield and funding cost. Weighted-average LTV was 65.5%, and the approved advance rate was 83.6%.

Non-mark-to-market financing made up 77.9% of the capital structure. The average loan size was $86.3 million.

Relative to peers shown in the presentation, TRTX’s current dividend yield of 11.4% ranked below KREF’s 15.0% and BXMT’s 13.7%, but above BRSP’s 11.1%, CMTG’s 10.3% and ARI’s 9.1%. Its price-to-book multiple of 0.76x was above CMTG’s 0.21x, ARI’s 0.24x, BXMT’s 0.56x, BRSP’s 0.82x and KREF’s 0.91x, while GPMT was shown at 0.90x. Following these announcements, the company's shares moved -0.77%, and are now trading at a price of $8.335. For the full picture, make sure to review TPG RE Finance Trust's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS